{"DataElement":{"publicId":"6346962","version":"1","preferredName":"Stem Cell Transplant Conditioning Type","preferredDefinition":"Information related to the type of conditioning regimen used to prepare a person for receipt of a stem cell transplant.","longName":"6346950v1.0:6346959v1.0","context":"Alliance","contextVersion":"1","DataElementConcept":{"publicId":"6346950","version":"1","preferredName":"Stem Cell Transplant Conditioning Type","preferredDefinition":"An unspecialized cell that has the capacity for reproduction through cell division and can be induced to differentiate into a tissue or organ specific cell._Administration of high doses of chemotherapy or radiation therapy, as well as immunosuppressive therapy, to a transplant recipient prior to a bone marrow or hematopoietic stem cell transplant.  Conditioning destroys the patient's abnormal blood cells or cancer, as well as slows the patient's immune response against the donor bone marrow (graft rejection)._Something distinguishable as an identifiable class based on common qualities.","longName":"6346948v1.0:2177317v1.0","context":"Alliance","contextVersion":"1","ObjectClass":{"publicId":"6346948","version":"1","preferredName":"Stem Cell Transplant Conditioning","preferredDefinition":"An unspecialized cell that has the capacity for reproduction through cell division and can be induced to differentiate into a tissue or organ specific cell.:Administration of high doses of chemotherapy or radiation therapy, as well as immunosuppressive therapy, to a transplant recipient prior to a bone marrow or hematopoietic stem cell transplant.  Conditioning destroys the patient's abnormal blood cells or cancer, as well as slows the patient's immune response against the donor bone marrow (graft rejection).","longName":"C12662:C64468","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stem Cell","conceptCode":"C12662","definition":"An unspecialized cell that has the capacity for reproduction through cell division and can be induced to differentiate into a tissue or organ specific cell.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Transplant Conditioning","conceptCode":"C64468","definition":"Administration of high doses of chemotherapy or radiation therapy, as well as immunosuppressive therapy, to a transplant recipient prior to a bone marrow or hematopoietic stem cell transplant.  Conditioning destroys the patient's abnormal blood cells or cancer, as well as slows the patient's immune response against the donor bone marrow (graft rejection).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7092C0AB-F184-740E-E053-F662850A5423","latestVersionIndicator":"Yes","beginDate":"2018-07-09","endDate":null,"createdBy":"MORENOC","dateCreated":"2018-07-09","modifiedBy":"ONEDATA","dateModified":"2018-07-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2177317","version":"1","preferredName":"Type","preferredDefinition":"Type; a subdivision of a particular kind of thing.","longName":"Type","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AE29A78C-52CB-3A05-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-10-29","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-10-29","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"Alliance Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7092C0AB-F192-740E-E053-F662850A5423","latestVersionIndicator":"Yes","beginDate":"2018-07-09","endDate":null,"createdBy":"MORENOC","dateCreated":"2018-07-09","modifiedBy":"MORENOC","dateModified":"2018-11-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6346959","version":"1","preferredName":"Stem Cell Transplant ConditioningType","preferredDefinition":"The type of conditioning regimen used to prepare a person for receipt of a stem cell transplant.","longName":"6346959v1.0","context":"Alliance","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Reduced-intensity or non-myeloablative","valueDescription":"Reduced Intensity Or Negation Myeloablative Agonist","ValueMeaning":{"publicId":"6346960","version":"1","preferredName":"Reduced Intensity Or Negation Myeloablative Agonist","longName":"6346960","preferredDefinition":"Made less in size or amount or degree.: The degree or magnitude of strength, energy, or feeling.: An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.: An operation in which a term denies or inverts the meaning of another term or construction.: Agents that destroy bone marrow activity. They are used to prepare patients for bone marrow or stem cell transplantation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Reduced","conceptCode":"C25640","definition":"Made less in size or amount or degree.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Intensity","conceptCode":"C25539","definition":"The degree or magnitude of strength, energy, or feeling.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Or","conceptCode":"C37998","definition":"An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Negation","conceptCode":"C25594","definition":"An operation in which a term denies or inverts the meaning of another term or construction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Myeloablative Agonist","conceptCode":"C1711","definition":"A pharmacological agent that kills cells in the bone marrow.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7094D509-6BD2-7B34-E053-F662850AA068","latestVersionIndicator":"Yes","beginDate":"2018-07-09","endDate":null,"createdBy":"MORENOC","dateCreated":"2018-07-09","modifiedBy":"ONEDATA","dateModified":"2018-07-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7094D509-6BEB-7B34-E053-F662850AA068","beginDate":"2018-07-09","endDate":null,"createdBy":"MORENOC","dateCreated":"2018-07-09","modifiedBy":"ONEDATA","dateModified":"2018-07-09","deletedIndicator":"No"},{"value":"Myeloablative/Full intensity","valueDescription":"Myeloablative Agonist Full Intensity","ValueMeaning":{"publicId":"6346961","version":"1","preferredName":"Myeloablative Agonist Full Intensity","longName":"6346961","preferredDefinition":"Agents that destroy bone marrow activity. They are used to prepare patients for bone marrow or stem cell transplantation.: Containing as much or as many as is possible or normal.: The degree or magnitude of strength, energy, or feeling.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Myeloablative Agonist","conceptCode":"C1711","definition":"A pharmacological agent that kills cells in the bone marrow.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Full","conceptCode":"C25517","definition":"Containing as much or as many as is possible or normal.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Intensity","conceptCode":"C25539","definition":"The degree or magnitude of strength, energy, or feeling.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7094D509-6BF9-7B34-E053-F662850AA068","latestVersionIndicator":"Yes","beginDate":"2018-07-09","endDate":null,"createdBy":"MORENOC","dateCreated":"2018-07-09","modifiedBy":"ONEDATA","dateModified":"2018-07-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7094D509-6C12-7B34-E053-F662850AA068","beginDate":"2018-07-09","endDate":null,"createdBy":"MORENOC","dateCreated":"2018-07-09","modifiedBy":"ONEDATA","dateModified":"2018-07-09","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2234813","version":"1","preferredName":"Type","preferredDefinition":"Type; a subdivision of a particular kind of thing.","longName":"C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F970CDF6-F90E-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"Alliance Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7094D509-6BB5-7B34-E053-F662850AA068","latestVersionIndicator":"Yes","beginDate":"2018-07-09","endDate":null,"createdBy":"MORENOC","dateCreated":"2018-07-09","modifiedBy":"MORENOC","dateModified":"2018-11-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"Stem cell transplant conditio","type":"Preferred Question Text","description":"Stem cell transplant conditioning","url":null,"context":"Alliance"}],"origin":"Alliance Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7095745D-E9EF-061D-E053-F662850A92E2","latestVersionIndicator":"Yes","beginDate":"2018-07-09","endDate":null,"createdBy":"MORENOC","dateCreated":"2018-07-09","modifiedBy":"MORENOC","dateModified":"2018-11-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}